These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 19661287)
61. Molecular mechanism of SHP2 activation by PD-1 stimulation. Marasco M; Berteotti A; Weyershaeuser J; Thorausch N; Sikorska J; Krausze J; Brandt HJ; Kirkpatrick J; Rios P; Schamel WW; Köhn M; Carlomagno T Sci Adv; 2020 Jan; 6(5):eaay4458. PubMed ID: 32064351 [TBL] [Abstract][Full Text] [Related]
62. Transmembrane peptide 4 and 5 of APJ are essential for its heterodimerization with OX1R. Wan L; Xu F; Liu C; Ji B; Zhang R; Wang P; Wu F; Pan Y; Yang C; Wang C; Chen J Biochem Biophys Res Commun; 2020 Jan; 521(2):408-413. PubMed ID: 31668922 [TBL] [Abstract][Full Text] [Related]
63. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. Bernier V; Stocco R; Bogusky MJ; Joyce JG; Parachoniak C; Grenier K; Arget M; Mathieu MC; O'Neill GP; Slipetz D; Crackower MA; Tan CM; Therien AG J Biol Chem; 2006 Aug; 281(34):24704-12. PubMed ID: 16790440 [TBL] [Abstract][Full Text] [Related]
64. Dual-agonist occupancy of orexin receptor 1 and cholecystokinin A receptor heterodimers decreases G-protein-dependent signaling and migration in the human colon cancer cell line HT-29. Bai B; Chen X; Zhang R; Wang X; Jiang Y; Li D; Wang Z; Chen J Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1153-1164. PubMed ID: 28288880 [TBL] [Abstract][Full Text] [Related]
65. The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells. Suo L; Chang X; Zhao Y Front Endocrinol (Lausanne); 2018; 9():647. PubMed ID: 30429828 [TBL] [Abstract][Full Text] [Related]
66. Blocking the PD-1 signal transduction by occupying the phosphorylated ITSM recognition site of SHP-2. Li W; Mei W; Jiang H; Wang J; Li X; Quan L; Diao Y; Ma Y; Fan S; Xie Z; Gong M; Zhu H; Bi D; Zhang F; Ma L; Zhang J; Gao Y; Paschalidis A; Lin H; Liu F; Liu K; Ye M; Zhao Z; Duan Y; Chen Z; Xu Y; Xiao W; Tao S; Zhu L; Li H Sci China Life Sci; 2024 Aug; ():. PubMed ID: 39235560 [TBL] [Abstract][Full Text] [Related]
67. Modeling of the OX1R-orexin-A complex suggests two alternative binding modes. Karhu L; Turku A; Xhaard H BMC Struct Biol; 2015 May; 15():9. PubMed ID: 25957175 [TBL] [Abstract][Full Text] [Related]
68. Copy number alteration of neuropeptides and receptors in multiple cancers. Zhao M; Wang T; Liu Q; Cummins S Sci Rep; 2017 Jul; 7(1):4598. PubMed ID: 28676692 [TBL] [Abstract][Full Text] [Related]
69. Synthesis and biological evaluation of F-18 labeled tetrahydroisoquinoline derivatives targeting orexin 1 receptor. Watanabe H; Fukui K; Shimizu Y; Idoko Y; Nakamoto Y; Togashi K; Saji H; Ono M Bioorg Med Chem Lett; 2019 Jul; 29(13):1620-1623. PubMed ID: 31056243 [TBL] [Abstract][Full Text] [Related]
70. Orexin A Affects INS-1 Rat Insulinoma Cell Proliferation via Orexin Receptor 1 and the AKT Signaling Pathway. Chen L; Zhao Y; Zheng D; Ju S; Shen Y; Guo L Int J Endocrinol; 2013; 2013():854623. PubMed ID: 24382962 [TBL] [Abstract][Full Text] [Related]
71. Mutation of PD-1 immune receptor tyrosine-based switch motif (ITSM) enhances the antitumor activity of cytotoxic T cells. Qi T; Fu J; Zhang W; Cui W; Xu X; Yue J; Wang Q; Tian X Transl Cancer Res; 2020 Nov; 9(11):6811-6819. PubMed ID: 35117290 [TBL] [Abstract][Full Text] [Related]
72. Japanese Herbal Medicine Ninjinyoeito Mediates Its Orexigenic Properties Partially by Activating Orexin 1 Receptors. Miyano K; Ohshima K; Suzuki N; Furuya S; Yoshida Y; Nonaka M; Higami Y; Yoshizawa K; Fujii H; Uezono Y Front Nutr; 2020; 7():5. PubMed ID: 32175325 [TBL] [Abstract][Full Text] [Related]
73. Ghrelin Through GHSR1a and OX1R Heterodimers Reveals a Gαs-cAMP-cAMP Response Element Binding Protein Signaling Pathway Xue Q; Bai B; Ji B; Chen X; Wang C; Wang P; Yang C; Zhang R; Jiang Y; Pan Y; Cheng B; Chen J Front Mol Neurosci; 2018; 11():245. PubMed ID: 30065627 [TBL] [Abstract][Full Text] [Related]
74. Machine learning models to predict ligand binding affinity for the orexin 1 receptor. Zhang VY; O'Connor SL; Welsh WJ; James MH Artif Intell Chem; 2024 Jun; 2(1):. PubMed ID: 38476266 [TBL] [Abstract][Full Text] [Related]
76. Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor. Patnaik S; Marugan JJ; Liu K; Zheng W; Southall N; Dehdashti SJ; Thorsell A; Heilig M; Bell L; Zook M; Eskay B; Brimacombe KR; Austin CP J Med Chem; 2013 Nov; 56(22):9045-56. PubMed ID: 24171469 [TBL] [Abstract][Full Text] [Related]
77. The study of membrane- or receptor-bound neuropeptides by NMR. Hicks RP Methods Mol Biol; 1997; 73():185-207. PubMed ID: 9031208 [No Abstract] [Full Text] [Related]
78. A single amino acid in MRGPRX2 necessary for binding and activation by pruritogens. Reddy VB; Graham TA; Azimi E; Lerner EA J Allergy Clin Immunol; 2017 Dec; 140(6):1726-1728. PubMed ID: 28689793 [No Abstract] [Full Text] [Related]
79. Structure-Affinity-Pharmacokinetics Relationships of Novel Ishizaka Y; Watanabe H; Ono M J Med Chem; 2024 Nov; 67(21):18781-18793. PubMed ID: 39431857 [TBL] [Abstract][Full Text] [Related]
80. Enzymatic self-assembly of an immunoreceptor tyrosine-based inhibitory motif (ITIM). Yamagata N; Chen X; Zhou J; Li J; Du X; Xu B Org Biomol Chem; 2017 Jul; 15(27):5689-5692. PubMed ID: 28675212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]